# EDGAR Filing Document

**Accession Number:** 0000896435
**File Stem:** 0001193125-23-078939
**Filing Date:** 2023-3
**Character Count:** 3781
**Document Hash:** 149ef65aba180fd5e890b1dfa4374786
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-078939.hdr.sgml**: 20230324

**ACCESSION NUMBER**: 0001193125-23-078939

**CONFORMED SUBMISSION TYPE**: 497K

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230324

**DATE AS OF CHANGE**: 20230324

**EFFECTIVENESS DATE**: 20230324

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS)
- **CENTRAL INDEX KEY:** 0000896435
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 497K
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 033-57340
- **FILM NUMBER:** 23759258

**BUSINESS ADDRESS:**
- **STREET 1:** 11 GREENWAY PLAZA
- **STREET 2:** SUITE 1000
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77046
- **BUSINESS PHONE:** 7136261919

**MAIL ADDRESS:**
- **STREET 1:** 11 GREENWAY PLAZA
- **STREET 2:** SUITE 1000
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77046

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AIM VARIABLE INSURANCE FUNDS
- **DATE OF NAME CHANGE:** 20000719

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AIM VARIABLE INSURANCE FUNDS INC
- **DATE OF NAME CHANGE:** 19930714

## Series and Classes Contracts Data

### Invesco(R) V.I. Nasdaq 100 Buffer Fund - March (Series ID: S000073044)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000229831 | Series I     |  |
| C000229832 | Series II    |  |

**SUPPLEMENT DATED MARCH 24, 2023 TO THE CURRENT** <br>**SUMMARY AND STATUTORY PROSPECTUSES FOR:** 

**Invesco® V.I. Nasdaq 100 Buffer Fund - March**

(the "Fund")

**This supplement amends the Summary and Statutory Prospectuses of the above referenced Fund and is in addition to any other supplement(s), unless otherwise specified.** *You should read this supplement carefully in conjunction with the Summary and Statutory Prospectuses and retain it for future reference.*

As described in the Prospectuses, the Fund seeks, over a specified annual outcome period (an "Outcome Period"), to provide investors with returns that match those of the Nasdaq 100 Index<sup>®</sup> (the "Underlying Index") up to an upside cap, while providing a buffer against the first 10% (prior to taking into account any fees and expenses of the Fund) of Underlying Index losses. The Fund's current Outcome Period will end on March 31, 2023, following which the Fund will reset and commence a new Outcome Period beginning April 1, 2023, as shown in the table below. At the beginning of the new Outcome Period, the Cap will reset.

The Fund's Cap will be determined at the end of the trading day immediately preceding the first day of the new Outcome Period, or March 31, 2023. As of the date of this Supplement, the Cap for the Fund for the new Outcome Period is expected to be within the range shown in the table below, before and after taking into account the Fund's fees and expenses:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **New Outcome Period** | **Fund's Current Cap** | **Estimated Cap Range** |
| April 1, 2023 to March 31, 2024 | 18.50% | Series I: 14.00% - 22.00% (before Fund fees and expenses)<br> Series II: 14.00% - 22.00% (before Fund fees and expenses)<br> Series I: 13.20% - 21.15% (after Fund fees and expenses)<br> Series II: 12.92% - 20.84% (after Fund fees and expenses)<br>|

---

The Fund's Cap is prior to taking into account any fees and expenses of the Fund, as described in the Fund's prospectus. These estimated cap ranges are based on market conditions as of March 24, 2023. The final Cap could fall outside of this range if there is a material change in market conditions between the date of this Supplement and the date on which the final Cap is established.

VINDQM-SUMSTAT-SUP

------